<--- Back to Details
First PageDocument Content
Chemistry / Opium / Illegal drug trade in Afghanistan / Opium production in Afghanistan / Illegal drug trade / Heroin / European Union / Euphoriants / Neurochemistry / Pharmacology
Date: 2011-10-20 03:59:01
Chemistry
Opium
Illegal drug trade in Afghanistan
Opium production in Afghanistan
Illegal drug trade
Heroin
European Union
Euphoriants
Neurochemistry
Pharmacology

The implementation of the 5th phase of the Central Asia Drug Action Programme (CADAP) Achievements and Challenges Second Regional Steering Committee Meeting (RSC) 11th October2011 in Astana, Kazakhstan Dr. Ingo Michels

Add to Reading List

Source URL: www.cadap.eu

Download Document from Source Website

File Size: 4,43 MB

Share Document on Facebook

Similar Documents

Microsoft Word - VLD Packet.FINAL

Microsoft Word - VLD Packet.FINAL

DocID: 1rubZ - View Document

Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone Atlanta, GA., August 13, 2013. Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical compa

Atlantic Pharmaceuticals Announces Successful Pre-IND Meeting with the FDA on Immediate Release, Abuse-Deterrent Hydrocodone Atlanta, GA., August 13, 2013. Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical compa

DocID: 1rtjz - View Document

TITAN	PHARMACEUTICALS	  CORPORATE	PRESENTATION	Ÿ	SUNIL	BHONSLE	Ÿ	JUNE	2016 ©	2016	TITAN	PHARMACEUTICALS	INC.	Ÿ	NASDAQ:TTNP

TITAN PHARMACEUTICALS CORPORATE PRESENTATION Ÿ SUNIL BHONSLE Ÿ JUNE 2016 © 2016 TITAN PHARMACEUTICALS INC. Ÿ NASDAQ:TTNP

DocID: 1rsmr - View Document

  “Hokus-Pokus Palliative Care” Case Report Gabriela Popescu, MD, M.Sc. Palliative Care, FMH Internal Medicine Tumor Zentrum and Hirslanden Klinik Aarau

“Hokus-Pokus Palliative Care” Case Report Gabriela Popescu, MD, M.Sc. Palliative Care, FMH Internal Medicine Tumor Zentrum and Hirslanden Klinik Aarau

DocID: 1rsfZ - View Document

Sunil Bhonsle  Mar 2015 Corporate Presentation

Sunil Bhonsle Mar 2015 Corporate Presentation

DocID: 1rrwl - View Document